Watchmaker Genomics, an innovator in high-performance solutions for next-generation sequencing (NGS), today announced a non-exclusive license with Caribou Biosciences, Inc., a leading clinical-stage ...

Every year, millions of newborns undergo routine screening as a preventive strategy to detect inherited disorders before ...

Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the ...

Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today launched the Twist TrueAmp ...

The DNBSEQ-T1+ is a next-generation mid-throughput sequencer that completes a paired end 150 sequencing workflow in just 24 hours with Q40 accuracy. With three flow cell formats, two to four ...

A novel blood based surveillance test using artificial intelligence and next-generation sequencing identified relapse a median of 41 days before clinical detection in patients with AML or MDS ...

Integrative oncology interest in persons with a cancer diagnosis. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full text component.

The presence or absence of remaining foreign DNA from the crossbred progeny of the genome-edited crop and the original crop cultivar can be determined by GenEditScan, based on the k-mer method.

A sequencing study conducted in Uganda reveals that one in four people has been exposed to a deadly hemorrhagic virus.

As next-generation sequencing (NGS) applications expand, researchers face growing pressure to generate accurate, uniform data from increasingly complex and low input samples.